Meta-analysis of the relationship between vasculogenic mimicry and poor prognosis in patients with colorectal cancer#br#
WANG Yitong1 JIANG Lujian2 LI Binbin2 ZUO Minghuan2 ZHOU Qin2
1.Center for Integrated Chinese and Western Medicine, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China;
2.Department of Oncology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
Abstract：Objective To investigate the relationship between vasculogenic mimicry (VM) and poor prognosis in patients with colorectal cancer. Methods The cohort studies on the relationship between VM and poor prognosis of colorectal cancer published in PubMed, Embase, Cochrane Library, Web of Science, CBM, CNKI, VIP, and Wanfang Data from inception to April 2021 were selected by computer. Then meta-analysis was performed by Stata 14.0 software. The pooled hazard ratio and its 95%CI were calculated. The subgroup analysis was performed. Results Five studies were included, including 769 patients and 203 VM positive patients. Meta-analysis showed a significant correlation between positive VM and poor prognosis (HR = 2.433, 95%CI: 1.844-3.023, P ＜ 0.001). Subgroup analysis showed that sample size, extraction method of patients’ prognosis, and comparability adjustment between groups had no significant influence on the correlation between VM positivity and patients’ prognosis (I2<50%, P > 0.1). Conclusion VM positive is significantly correlated with poor prognosis of colorectal cancer, and VM can be a potential direction for clinical treatment of colorectal cancer.
王一同1 蒋璐剑2 李彬彬2 左明焕2 周琴2. 血管生成拟态与结直肠癌不良预后相关性的meta分析[J]. 中国医药导报, 2021, 18(35): 97-100.
WANG Yitong1 JIANG Lujian2 LI Binbin2 ZUO Minghuan2 ZHOU Qin2. Meta-analysis of the relationship between vasculogenic mimicry and poor prognosis in patients with colorectal cancer#br#. 中国医药导报, 2021, 18(35): 97-100.
[1] Siegel RL，Miller KD，Jemal A，et al. Cancer statistics，2020 [J]. CA Cancer J Clin，2020，70（1）：7-30.
[2] 顾晋，汪建平.中国结直肠癌诊疗规范（2017年版）[J].中华临床医师杂志：电子版，2018，12（1）：3-23.
[3] 陈崇彬，李树斌，沈玲.结直肠癌患者病理特征与预后的相关性分析[J].中国肛肠病杂志，2019，39（10）：1-3.
[4] 鲁美钰，仲维兰，司春枫，等.肿瘤血管生成机制及抗肿瘤血管新生的靶向药物研究进展[J].安徽医药，2018，22（5）：798-802.
[5] Di MJ，Rotondo F，Kovacs K，et al. Vasculogenic Mimicry in Clinically Non-functioning Pituitary Adenomas：A Histologic Study [J]. Pathol Oncol Res，2017，23（4）：803-809.
[6] Baeten CIM，Hillen F，Pauwels P，et al. Prognostic role of vasculogenic mimicry in colorectal cancer [J]. Dis Colon Rectum，2009，52（12）：2028-2035.
[7] Maniotis AJ，Folberg R，Hess A，et al. Vascular channel formation by human melanoma cells in vivo and in vitro：vasculogenic mimicry [J]. Am J Pathol，1999，155（3）：739-752.
[8] Sun B，Zhang S，Zhao X，et al. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas [J]. Int J Oncol，2004，25（6）：1609-1614.
[9] Dunleavey JM，Xiao L，Thompson J，et al. Vascular channels formed by subpopulations of PECAM1 melanoma cells [J]. Nat Commun，2014，5：5200.
[10] 俞岚，武世伍，周蕾，等.细菌L型感染、低氧诱导因子-1α及MMP-9表达与卵巢上皮性癌血管生成拟态的关系[J].生理学报，2012，64（6）：657-665.
[11] Sun Q，Zou X，Zhang T，et al. The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer [J]. Gynecol Oncol，2014，132（3）：730-738.
[12] Sun B，Zhang S，Zhang D，et al. Vasculogenic mimicry is associated with high tumor grade，invasion and metastasis，and short survival in patients with hepatocellular carcinoma [J]. Oncol Rep，2006，16（4）：693-698.
[13] Liu WB，Xu GL，Jia WD，et al. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma [J]. Med Oncol，2011，28（Suppl 1）：S228-S238.
[14] 郭秋均.西黄丸抑制胃癌细胞增殖及其血管生成拟态形成的机制探讨[D].北京：北京中医药大学，2017.
[15] Liu T，Sun B，Zhao X，et al. OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer [J]. Int J Mol Sci，2014，15（11）：19634-19649.
[16] Tierney JF，Stewart LA，Ghersi D，et al. Practical methods for incorporating summary time-to event data into meta-analysis [J]. Trials，2007，8：16.
[17] Lo CK，Mertz D，Loeb M. Newcastle-Ottawa Scale：comparing reviewers to authors’ assessments [J]. BMC Med Res Methodol，2014，14：45.
[18] 庞春光，孙保存，赵秀兰，等.大肠癌中αvβ3 integrin表达与血管生成拟态的关系及分子机制的研究[J].中国肿瘤临床，2013，40（10）：555-559.
[19] Su YJ，Zhang JX，Li SM，et al. Relationship of vasculogenic mimicry，SphK1 expression，and Cx43 expression to metastasis and prognosis in colorectal cancer [J]. Int J Clin Exp Pathol，2018，11（11）：5290-5299.
[20] Zhu B，Zhou L，Yu L，et al. Evaluation of the correlation of vasculogenic mimicry，ALDH1，KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma [J]. BMC Surg，2017，17（1）：47.
[21] 慈红非，武世伍，柴大敏，等.血管生成拟态在直肠腺癌中的临床病理意义[J].蚌埠医学院学报，2019，44（1）：28-30.
[22] 李明玉，贾喜花.结肠癌组织血管生成抑制素结合蛋白、迁移诱导蛋白-7、MMP-2表达及其与血管生成拟态的相关性[J].山东医药，2019，59（6）：5-8.
[23] 夏龙飞，刘玉君，张军民，等.CEACAM-1在结直肠癌中的表达及与肿瘤血管生成、转移的相关性研究[J].中国医药导报，2019，16（2）：94-97，182.
[24] 崔立山，林婷，张健莉，等.下调垂体瘤转化基因1对胶质瘤细胞SHG44血管生成拟态及细胞周期的影响[J].中国医药科学，2020，10（17）：43-47.
[25] 田翀，高青.结肠癌血管生成拟态的形态学观察及生成机制[J].第四军医大学学报，2009，30（22）：2568-2571.
[26] 方虹，周忠明，李云君，等.Notch1信号通路与宫颈癌血管生成拟态的相关性[J].中国医药导报，2019，16（21）：88-92.
[27] Liu Z，Sun B，Qi L，et al. Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition [J]. Cancer Sci，2012，103（4）：813-820.
[28] Yang JP，Liao YD，Mai DM，et al. Tumor vasculogenic mimicry predicts poor prognosis in cancer patients：a meta-analysis [J]. Angiogenesis，2016，19（2）：191-200.
[29] 吴燕彬，王学文，牛洪凯，等.保护性自噬调控胆管癌等恶性肿瘤细胞血管生成拟态形成的研究现状[J].临床肝胆病杂志，2019，35（8）：1882-1884.
[30] 罗翠莲.肿瘤抗血管生成治疗耐药分子机制研究进展[J].肿瘤预防与治疗，2014，27（1）：33-38.
京公网安备 11010502046598号